欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Cyclin-dependent Kinase (CDK)-BLU-222
BLU-222

Chemical Structure : BLU-222

CAS No.: 2888704-84-3

BLU-222 (Cirtociclib, BLU222)

货号: PC-23995Not For Human Use, Lab Use Only.

Cirtociclib (BLU-222) is a potent, highly selective, ATP-competitive CDK2 inhibitor with IC50 of 2.6 nM (CDK2/cyclinE1) with strong selectivity (>200-fold) over CDK family members (1/4/6/7/9).

规格 价格 库存 数量
5 mg ¥2180 In stock
10 mg ¥3580 In stock
25 mg ¥5880 In stock
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Cirtociclib (BLU-222) is a potent, highly selective, ATP-competitive CDK2 inhibitor with IC50 of 2.6 nM (CDK2/cyclinE1) with strong selectivity (>200-fold) over CDK family members (1/4/6/7/9).
BLU-222 has excellent kinome selectivity with an S(10) of 0.045, measured by KINOMEscan at 3 µM.
BLU-222 displays nanomolar cellular potency on phosphorylated Rb (pRb) T821/826 with strong selectivity over pLamin S22, a measure of CDK1 activity in CDK2-dependent cell line OVCAR-3.
BLU-222 displays nanomolar cellular potency on phosphorylated Rb (pRb) T821/826 with strong selectivity over pLamin S22, a measure of CDK1 activity. BLU-222 potently and dose-dependently inhibited proliferation in CCNE1amplified ovarian/endometrial cancer cell lines, while sparing CCNE1-normal (diploid, mRNA not overexpressed) cell lines.
BLU-222 disrupts Rb signaling in CCNE1-amplified cells to arrest cell cycle progression. BLU-222 demonstrated robust activity in combination with carboplatin or paclitaxel in CCNE1-aberrant models, rendering chemotherapy-resistant tumors strongly sensitive to the combination.

物理化学性质&存储条件

分子量 365.34
分子式 C15H17F2N7O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(5-(difluoromethoxy)-1H-pyrazol-3-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-pyrazolo[3,4-b]pyrazin-6-amine

参考文献

1. Dommer AP, et al. Cancer Res. 2025 Feb 13. doi: 10.1158/0008-5472.CAN-24-2244.

2. House NC, et al. Cancer Res. 2025 Feb 13. doi: 10.1158/0008-5472.CAN-24-2360.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: